SCHEMBL7792900

SCHEMBL7792900

Oc1ccc2[nH]c(-c3ccc(C45CC6CC(CC(C6)C4)C5)c(O)c3)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 1/20 0.39
PRKD3 O94806 1/20 0.39
PAK4 O96013 1/20 0.39
PDGFRA P16234 1/20 0.39
LTK P29376 1/20 0.39
MAP2K2 P36507 1/20 0.39
MAPK8 P45983 1/20 0.39
CDK8 P49336 1/20 0.39
RPS6KA3 P51812 1/20 0.39
PRKX P51817 1/20 0.39
NEK2 P51955 1/20 0.39
LIMK1 P53667 1/20 0.39
CDK5 Q00535 1/20 0.39
PRKCQ Q04759 1/20 0.39
MAP4K2 Q12851 1/20 0.39
ROCK1 Q13464 1/20 0.39
LRRK2 Q5S007 1/20 0.39
TAOK1 Q7L7X3 1/20 0.39
AURKB Q96GD4 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7786883 0.91 RARB (0.46) CHEK1PRKD3PAK4PDGFRALTK
SCHEMBL7792906 0.91 CHEK1 (0.50) CHEK1PRKD3PAK4PDGFRALTK
SCHEMBL7786877 0.84 RARA (0.49) CHEK1MEN1KMT2AALDH1A1HPGD
SCHEMBL7786885 0.81 CHEK1 (0.50) CHEK1PRKD3PAK4PDGFRALTK
SCHEMBL7786833 0.78 AMY1A (0.46) CHEK1MEN1KMT2ARARBRARA
SCHEMBL9286338 0.78 SMN1; SMN2 (0.47) MEN1KMT2AALDH1A1HPGDSMN1; SMN2
SCHEMBL7052839 0.77 RARG (0.64) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7795164 0.77 MEN1 (0.45) MEN1KMT2ATHRBRECQLNR2E1
SCHEMBL7786884 0.75 RARA (0.49) CHEK1PRKD3PAK4PDGFRALTK
SCHEMBL2420330 0.75 MEN1 (0.50) MEN1KMT2ATHRBRECQLNR2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP claimed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US claimed
EP-0643701-B1 BENZIMIDAZOLE-DERIVED COMPOUNDS, METHOD FOR PREPARING SAME, AND THERAPEUTICAL AND COSMETIC USES THEREOF CT INTERNAT DE RECH S BR DERMA (FR) 2001-12-05 EP disclosed
US-5446059-A Treating or preventing inflammatory or immunoallergic conditions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-08-29 US disclosed